Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Dividends
  • Earnings
  • News

Here’s How Much $100 Invested In Elevance Health 5 Years Ago Would Be Worth Today

By Benzinga Insights
Today, 3:34 PM
Elevance Health (NYSE:ELV) has outperformed the market over the past 5 years by 7.62% on an annualized basis…

ELV

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

SVB Leerink Reiterates Outperform on Elevance Health, Maintains $580 Price Target

By Benzinga Newsdesk
Today, 3:34 PM
SVB Leerink analyst Whit Mayo reiterates Elevance Health (NYSE:ELV) with a Outperform and maintains $580 price target.

ELV

Read More
1 minute read
  • Earnings
  • News

Elevance Health Q4 EPS $5.23 Beats $5.19 Estimate, Sales $39.67B Miss $39.76B Estimate

By Bill Haddad
Today, 3:34 PM
Elevance Health (NYSE:ELV) reported quarterly earnings of $5.23 per share which beat the analyst consensus estimate of $5.19 by 0.77 percent. This is a 1.75 percent increase over earnings of $5.14 per share from the same

ELV

Read More
4 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Legal
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Top Stories
  • Trading Ideas

Trump Beefs Up Defamation War Against New York Prosecutor, Apple Weighs Content Deals With Disney, Likely Lawsuit On Google For Influencing Online Ad Market: Today’s Top Stories

By Vandana Singh
Today, 3:34 PM
Benzinga

AAPL

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • M&A
  • News

Elevance To Acquire Louisiana Nonprofit Health Insurer, Adds 1.9M Members

By Vandana Singh
Today, 3:34 PM
Elevance Health Inc (NYSE:ELV) agreed to acquire Blue Cross and Blue Shield of Louisiana, joining Elevance Health’s affiliated Anthem Blue Cross…

ELV

Read More
1 minute read
  • Earnings

Elevance Health Earnings Conference Call Is Coming Up, Here’s What You Need To Know

By Benzinga Insights
Today, 3:34 PM
Elevance Health (NYSE:ELV) will host a conference call at 08:30 AM ET on January 25, 2023, to discuss…

ELV

Read More
4 minute read
  • Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights
Today, 3:34 PM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

BSX

Read More
1 minute read
  • Analyst Ratings

What 5 Analyst Ratings Have To Say About Elevance Health

By Benzinga Insights
Today, 3:34 PM
Within the last quarter, Elevance Health (NYSE:ELV) has observed the following analyst ratings:

ELV

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Mizuho Maintains Buy on Elevance Health, Raises Price Target to $575

By Benzinga Newsdesk
Today, 3:34 PM
Mizuho analyst Ann Hynes maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $545 to $575.

ELV

Read More
1 minute read
  • Dividends
  • Earnings
  • News

Here’s How Much $1000 Invested In Elevance Health 15 Years Ago Would Be Worth Today

By Benzinga Insights
Today, 3:34 PM
Elevance Health (NYSE:ELV) has outperformed the market over the past 15 years by 7.22% on an annualized basis producing an average annual return of 13.18%. Currently, Elevance Health has a market capitalization of $120.43 billion.

ELV

Posts navigation

1 2 3 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service